New math formula could make lithium blood tests more flexible for bipolar patients
NCT ID NCT07306039
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new method called eLi12 that estimates lithium levels in the blood even when the blood test isn't taken exactly 12 hours after the last dose. Researchers want to see if 200 people with bipolar disorder can reliably record when they took their lithium, and whether eLi12 gives more consistent results than standard tests. The goal is to make lithium monitoring more convenient for patients and clinicians.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER (BD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinic for Bipolar Disorder, Aarhus University Hospital Psychiatry
Aarhus, Denmark
-
Psychiatric Hospital Gødstrup
Herning, Denmark
-
Psychiatric Hospital Randers
Randers, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the immune system hold the key to treating resistant mental illness?
- Gold nanoparticles may make lithium therapy safer and more effective
- Talking back to stigma: can psychoeducation ease the hidden burden of bipolar disorder?
- Targeted magnetic pulses aim to lift bipolar depression
- New hope for bipolar depression? pramipexole trial targets anhedonia
- Can VR games sharpen the minds of people with mental illness?